Investor Relations - Curis http://investors.curis.com/ Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) http://investors.curis.com/2018-07-09-Curis-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4 Mon, 09 Jul 2018 10:33:00 -0400 http://investors.curis.com/2018-07-09-Curis-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4 /C O R R E C T I O N -- Curis, Inc./ http://investors.curis.com/2018-05-31-C-O-R-R-E-C-T-I-O-N-Curis-Inc Thu, 31 May 2018 08:30:00 -0400 http://investors.curis.com/2018-05-31-C-O-R-R-E-C-T-I-O-N-Curis-Inc Curis Announces Effectiveness of 1-for-5 Reverse Stock Split http://investors.curis.com/2018-05-29-Curis-Announces-Effectiveness-of-1-for-5-Reverse-Stock-Split Tue, 29 May 2018 10:10:00 -0400 http://investors.curis.com/2018-05-29-Curis-Announces-Effectiveness-of-1-for-5-Reverse-Stock-Split Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development http://investors.curis.com/2018-05-24-Curis-Expands-Senior-Management-Expertise-with-Appointment-of-Robert-Martell-M-D-Ph-D-as-Head-of-Research-and-Development - Dr. David Tuck, CMO, to retire and return to academia - Thu, 24 May 2018 07:00:00 -0400 http://investors.curis.com/2018-05-24-Curis-Expands-Senior-Management-Expertise-with-Appointment-of-Robert-Martell-M-D-Ph-D-as-Head-of-Research-and-Development Curis Announces 1-for-5 Reverse Stock Split http://investors.curis.com/2018-05-22-Curis-Announces-1-for-5-Reverse-Stock-Split Tue, 22 May 2018 17:55:00 -0400 http://investors.curis.com/2018-05-22-Curis-Announces-1-for-5-Reverse-Stock-Split